Applied Biosystems has expanded its portfolio of capillary electrophoresis sequencing systems with the introduction of two lines of genetic analysers.
Both platforms will provide advancements in CE sequencing systems, and aim to set new standards for throughput, data quality and ease of use.
The 3500 DX Series genetic analysers are intended for use by trained operators in the analysis of human DNA or RNA, for the detection of genetic changes that may lead to disease presence or susceptibility.
This system will be distributed and used in specific European countries only, including France, Germany, Italy, the Netherlands, Spain, Sweden, and the UK.
It represents the first CE system and accessories to comply with the European Union In Vitro Diagnostic Medical Devices Directive 98/79/EC.
Commercial launch of the 3500 DX Series systems is anticipated in August 2009.
The 3500 Series enables researchers to run up to 1,100 sequencing or 1,200 genotyping samples per day.
It features designs that incorporate the ability to track key information with radio frequency identification (RFID) tags, new optical and thermal systems designs, and redesigned data collection and analysis software.
The 3500 Series systems are for research use only, and are anticipated to be commercially available in August 2009.
Dr Roland Achmann, MVZ Genteq, said: 'The results we obtained with the 3500 Series were of good quality and absolutely comparable with the data we receive with our current capillary electrophoresis platform.
'In addition to quality results, the system also offers certain features that allow us to shorten the time to results, which is a very important advantage in our continuing effort to optimise our analysis workflow,' he added.
